Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Efficient pre-catalytic conformational change of reverse transcriptases from SAMHD1 non-counteracting primate lentiviruses during dNTP incorporation.

Coggins SA, Holler JM, Kimata JT, Kim DH, Schinazi RF, Kim B.

Virology. 2019 Aug 14;537:36-44. doi: 10.1016/j.virol.2019.08.010. [Epub ahead of print]

2.

Correction: The viral restriction factor Tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with Beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy.

Zou J, Li W, Misra A, Yue F, Song K, Chen Q, Guo G, Yi J, Kimata JT, Liu L.

J Biol Chem. 2019 Mar 29;294(13):5211. doi: 10.1074/jbc.AAC119.008256. No abstract available.

3.

Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection.

Auclair S, Liu F, Niu Q, Hou W, Churchyard G, Morgan C, Frahm N, Nitayaphan S, Pitisuthithum P, Rerks-Ngarm S, Kimata JT, Soong L, Franchini G, Robb M, Kim J, Michael N, Hu H.

PLoS Pathog. 2018 Feb 23;14(2):e1006888. doi: 10.1371/journal.ppat.1006888. eCollection 2018 Feb.

4.

Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.

Misra A, Gleeson E, Wang W, Ye C, Zhou P, Kimata JT.

J Virol. 2018 Mar 14;92(7). pii: e02080-17. doi: 10.1128/JVI.02080-17. Print 2018 Apr 1.

5.

Replication of Zika Virus in Human Prostate Cells: A Potential Source of Sexually Transmitted Virus.

Spencer JL, Lahon A, Tran LL, Arya RP, Kneubehl AR, Vogt MB, Xavier D, Rowley DR, Kimata JT, Rico-Hesse RR.

J Infect Dis. 2018 Jan 30;217(4):538-547. doi: 10.1093/infdis/jix436.

6.

Plasma Levels of Complement Factor I and C4b Peptides Are Associated with HIV Suppression.

Wu B, Ouyang Z, Lyon CJ, Zhang W, Clift T, Bone CR, Li B, Zhao Z, Kimata JT, Yu XG, Hu Y.

ACS Infect Dis. 2017 Dec 8;3(12):880-885. doi: 10.1021/acsinfecdis.7b00042. Epub 2017 Sep 15.

7.

Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector.

He H, Xue J, Wang W, Liu L, Ye C, Cong Z, Kimata JT, Qin C, Zhou P.

Hum Gene Ther. 2017 Mar;28(3):271-285. doi: 10.1089/hum.2016.135. Epub 2016 Dec 29.

8.

Challenges and strategies for the eradication of the HIV reservoir.

Kimata JT, Rice AP, Wang J.

Curr Opin Immunol. 2016 Oct;42:65-70. doi: 10.1016/j.coi.2016.05.015. Epub 2016 Jun 9. Review.

9.

The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.

Liu L, Wang W, Matz J, Ye C, Bracq L, Delon J, Kimata JT, Chen Z, Benichou S, Zhou P.

J Virol. 2016 Nov 14;90(23):10642-10659. doi: 10.1128/JVI.01559-16. Print 2016 Dec 1.

10.

Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor.

Liu L, Wen M, Zhu Q, Kimata JT, Zhou P.

J Neuroimmune Pharmacol. 2016 Sep;11(3):601-10. doi: 10.1007/s11481-016-9681-x. Epub 2016 May 7.

11.

Subversion of Cell Cycle Regulatory Mechanisms by HIV.

Rice AP, Kimata JT.

Cell Host Microbe. 2015 Jun 10;17(6):736-40. doi: 10.1016/j.chom.2015.05.010. Review.

12.

The viral restriction factor tetherin prevents leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) from association with beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and enhances autophagy and mitophagy.

Zou J, Li W, Misra A, Yue F, Song K, Chen Q, Guo G, Yi J, Kimata JT, Liu L.

J Biol Chem. 2015 Mar 13;290(11):7269-79. doi: 10.1074/jbc.M114.627679. Epub 2015 Jan 28. Erratum in: J Biol Chem. 2019 Mar 29;294(13):5211.

13.

CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection.

Wang W, Ye C, Liu J, Zhang D, Kimata JT, Zhou P.

PLoS One. 2014 Dec 26;9(12):e115987. doi: 10.1371/journal.pone.0115987. eCollection 2014.

14.

Stepping toward a macaque model of HIV-1 induced AIDS.

Kimata JT.

Viruses. 2014 Sep 25;6(9):3643-51. doi: 10.3390/v6093643. Review.

15.

HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies.

Couturier J, Hutchison AT, Medina MA, Gingaras C, Urvil P, Yu X, Nguyen C, Mahale P, Lin L, Kozinetz CA, Schmitz JE, Kimata JT, Savidge TC, Lewis DE.

Virology. 2014 Aug;462-463:175-88. doi: 10.1016/j.virol.2014.06.008. Epub 2014 Jul 4.

16.

Macaques as model hosts for studies of HIV-1 infection.

Misra A, Thippeshappa R, Kimata JT.

Front Microbiol. 2013 Jun 28;4:176. doi: 10.3389/fmicb.2013.00176. Print 2013.

17.

A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Thippeshappa R, Ruan H, Wang W, Zhou P, Kimata JT.

J Virol. 2013 Jun;87(12):6678-92. doi: 10.1128/JVI.00338-13. Epub 2013 Apr 3.

18.

Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.

Thippeshappa R, Ruan H, Kimata JT.

Biology (Basel). 2012 May 12;1(2):134-64. doi: 10.3390/biology1020134.

19.

Trimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitor.

Liu L, Wang W, Yang L, Ren H, Kimata JT, Zhou P.

J Virol. 2013 Feb;87(3):1899-905. doi: 10.1128/JVI.01038-12. Epub 2012 Nov 14.

20.

Vpx is critical for SIVmne infection of pigtail macaques.

Belshan M, Kimata JT, Brown C, Cheng X, McCulley A, Larsen A, Thippeshappa R, Hodara V, Giavedoni L, Hirsch V, Ratner L.

Retrovirology. 2012 Apr 24;9:32. doi: 10.1186/1742-4690-9-32.

21.

Absence of XMRV in peripheral blood mononuclear cells of ARV-treatment naïve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors.

Gingaras C, Danielson BP, Vigil KJ, Vey E, Arduino RC, Kimata JT.

PLoS One. 2012;7(2):e31398. doi: 10.1371/journal.pone.0031398. Epub 2012 Feb 13.

22.

Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.

Liu L, Wen M, Wang W, Wang S, Yang L, Liu Y, Qian M, Zhang L, Shao Y, Kimata JT, Zhou P.

J Virol. 2011 Sep;85(17):8467-76. doi: 10.1128/JVI.00520-11. Epub 2011 Jun 29.

23.

Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Thippeshappa R, Polacino P, Yu Kimata MT, Siwak EB, Anderson D, Wang W, Sherwood L, Arora R, Wen M, Zhou P, Hu SL, Kimata JT.

J Virol. 2011 Apr;85(8):3767-79. doi: 10.1128/JVI.02438-10. Epub 2011 Feb 2.

24.

Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation.

Biesinger T, White R, Yu Kimata MT, Wilson BK, Allan JS, Kimata JT.

Retrovirology. 2010 Oct 13;7:88. doi: 10.1186/1742-4690-7-88.

26.

GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.

Wen M, Arora R, Wang H, Liu L, Kimata JT, Zhou P.

Retrovirology. 2010 Oct 6;7:79. doi: 10.1186/1742-4690-7-79.

27.

Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levels.

Arora R, Bull L, Siwak EB, Thippeshappa R, Arduino RC, Kimata JT.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):115-21. doi: 10.1097/QAI.0b013e3181daaf98.

28.

A decrease in albumin in early SIV infection is related to viral pathogenicity.

Graham SM, Holte S, Kimata JT, Wener MH, Overbaugh J.

AIDS Res Hum Retroviruses. 2009 Apr;25(4):433-40. doi: 10.1089/aid.2008.0267.

30.

HIV-1 Transmission, Replication Fitness and Disease Progression.

Biesinger T, Kimata JT.

Virology (Auckl). 2008 Jul 14;2008(1):49-63.

32.

Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.

Ambrose Z, Palmer S, Boltz VF, Kearney M, Larsen K, Polacino P, Flanary L, Oswald K, Piatak M Jr, Smedley J, Shao W, Bischofberger N, Maldarelli F, Kimata JT, Mellors JW, Hu SL, Coffin JM, Lifson JD, KewalRamani VN.

J Virol. 2007 Nov;81(22):12145-55. Epub 2007 Sep 12.

33.

Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge.

Polacino P, Cleveland B, Zhu Y, Kimata JT, Overbaugh J, Anderson D, Hu SL.

J Med Primatol. 2007 Aug;36(4-5):254-65.

PMID:
17669214
34.

ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission.

Biggins JE, Biesinger T, Yu Kimata MT, Arora R, Kimata JT.

Virology. 2007 Aug 1;364(2):383-94. Epub 2007 Apr 16.

35.
36.

Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes.

Liu H, Dow EC, Arora R, Kimata JT, Bull LM, Arduino RC, Rice AP.

J Virol. 2006 Aug;80(15):7765-8.

37.

HIV-1 fitness and disease progression: insights from the SIV-macaque model.

Kimata JT.

Curr HIV Res. 2006 Jan;4(1):65-77. Review.

PMID:
16454712
39.

Domains of macaque DC-SIGN essential for capture and transfer of simian immunodeficiency virus.

Biggins JE, Yu Kimata MT, Kimata JT.

Virology. 2004 Jun 20;324(1):194-203.

40.

Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN.

Yu Kimata MT, Cella M, Biggins JE, Rorex C, White R, Hicks S, Wilson JM, Patel PG, Allan JS, Colonna M, Kimata JT.

J Virol. 2002 Dec;76(23):11827-36.

41.
42.

Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN.

Baribaud F, Pöhlmann S, Sparwasser T, Kimata MT, Choi YK, Haggarty BS, Ahmad N, Macfarlan T, Edwards TG, Leslie GJ, Arnason J, Reinhart TA, Kimata JT, Littman DR, Hoxie JA, Doms RW.

J Virol. 2001 Nov;75(21):10281-9.

43.

Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression.

Kimata JT, Kuller L, Anderson DB, Dailey P, Overbaugh J.

Nat Med. 1999 May;5(5):535-41.

PMID:
10229230
44.

Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne.

Kimata JT, Gosink JJ, KewalRamani VN, Rudensey LM, Littman DR, Overbaugh J.

J Virol. 1999 Feb;73(2):1655-60.

47.
49.

Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.

Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L.

Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1057-61.

50.

Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones.

Kimata JT, Wong FH, Wang JJ, Ratner L.

Virology. 1994 Nov 1;204(2):656-64.

PMID:
7941334

Supplemental Content

Loading ...
Support Center